Neurogene (NGNE) Return on Equity [ROE] (2014 - 2026)
Neurogene's Return on Equity [ROE] was -49.08% in Q2 2026, down 18.83 percentage points from -30.25% a year earlier and down 9.23 percentage points from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Neurogene came in at -31.91%, down 2.04 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -11.65 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -29.88% in FY2024 (+231.48 pp), -261.36% in FY2023 and -122.20% in FY2021 (-101.94 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q4 2023.
- Compared with a year earlier, Return on Equity [ROE] has declined for three straight quarters, with an average year-over-year change of +528.92 percentage points over the last seven quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2024 (a gain of 3707.13 percentage points); the worst was Q1 2022 (a drop of 298.43 percentage points).
- Per Business Quant data, NGNE's Return on Equity [ROE] in the three quarters before Q2 2026 was -39.85% (Q1 2026), -34.61% (Q4 2025) and -31.99% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - | -49.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.08% |
| Mar 31, 2026 | -39.85% |
| Dec 31, 2025 | -34.61% |
| Sep 30, 2025 | -31.99% |
| Jun 30, 2025 | -30.25% |
| Mar 31, 2025 | -26.70% |
| Dec 31, 2024 | -33.12% |
| Sep 30, 2024 | -47.10% |
| Jun 30, 2024 | -38.73% |
| Mar 31, 2024 | -31.86% |
| Dec 31, 2023 | -3,740.25% |
| Sep 30, 2022 | -53.98% |
| Jun 30, 2022 | -50.13% |
| Mar 31, 2022 | -319.82% |
| Dec 31, 2021 | -192.72% |
| Sep 30, 2021 | -36.13% |
| Jun 30, 2021 | -25.99% |
| Mar 31, 2021 | -21.40% |
| Dec 31, 2020 | -17.01% |
| Sep 30, 2020 | -17.63% |
API Access
Neurogene Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();